HomeLatest NewsICMR defends move to fast-track clinical trial of COVID-19 vaccine; Says process...

ICMR defends move to fast-track clinical trial of COVID-19 vaccine; Says process is in accordance with globally accepted norms

Indian Council of Medical Research (ICMR) has asserted that it is acting in accordance with the globally accepted norms to fast-track vaccine development for diseases of pandemic potential. It said, it is important to promote indigenous vaccine development while ensuring safety, quality, ethics and adherence to all regulatory requirement.

ICMR and Bharat Biotech have joined hands for the development of potential COVID-19 vaccine called Covaxin. The Drugs Controller General of India has accorded permission to conduct phase-1 and 2 human clinical trial.

Also Read: Coronavirus vaccine update: ICMR-Bharat Biotech Covaxin test results to be released on August 15

ICMR said, in the larger public health interest, it is important for ICMR to expedite the clinical trials with a promising indigenous vaccine.

39 COMMENTS

  1. Hello, i think that i saw you visited my website so i came to “return the favor”.I am trying to find things to enhance my web site!I suppose its ok to use a few of your ideas!!

  2. You have made some good points there. I checked on the web to find out more about the issue and found most individuals will go along with your views on this site.

  3. I am really impressed along with your writing abilities and also with
    the format in your weblog. Is this a paid subject matter or did you modify
    it your self? Either way keep up the nice high quality writing, it is uncommon to look a great weblog like this one nowadays..

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img